Respir 0.5 mg / ml nasal spray 20ml.

More info

Respir 0.5 mg / ml nasal spray solution is a prescription without a prescription.

International Pharmacy recommends downloading the prospect of this medicine before use. This leaflet is in Spanish (from Spain).
Respir 0.5 mg / ml nasal spray
Oxymetazoline hydrochloride
 
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Follow exactly the instructions of drug administration in this leaflet or as your doctor or pharmacist.
Keep this leaflet, as you may need to read it again.
If you need more information or advice, consult your pharmacist.
If you experience side effects, consult your doctor or pharmacist, even if it comes to possible side effects not listed in this leaflet.
You should consult a doctor if worsens or does not improve after 3 days.
 
In this leaflet:
1. What it is Respir and what it is used
2. What you need to know before you start using Respir
3. Using Respir
4. Possible side effects
5. Conservation Respir
6. Contents of the pack and other information

1. What it is Respir and what it is used
This drug belongs to the group of drugs called sympathomimetic. It is a nasal decongestant oxymetazoline medicine containing as an active ingredient. Oxymetazoline administered through the nose, causes constriction of blood vessels locally, decongesting the nasal mucosa.
It is indicated for local and temporary relief of nasal congestion in adults and children aged 6 years.
You should consult a doctor if worsens or does not improve after 3 days of treatment.

Authorization holder responsible for marketing and manufacturing
 
Holder of the marketing authorization:
Bayer Hispania, S.L.
Avda Baix Llobregat, No. 3 -. 5
08970 Sant Joan Despi (Barcelona)
Spain
 
Responsible for manufacturing:
Berlimed S.A.
C / Francisco Alonso # 7
Santa Rosa Industrial Park (Alcalá de Henares)
28806 Madrid
or
Schering-Plough Labo N.V.
Industriepark 30
B-2220 Heist-op-den-Berg
Belgium
 
Date of last revision of this leaflet: 02/2016
 
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Do you like this product?